CRISPR Therapeutics AG Uncategorized Contracts & Agreements
10 Contracts & Agreements
- Description of Capital Shares (Filed With SEC on February 21, 2024)
- Letter Agreement dated January 6, 2022, by and between CRISPR Therapeutics, Inc. and 105 W First Street Owner, L.L.C (Filed With SEC on February 15, 2022)
- Letter Agreement dated December 16, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc (Filed With SEC on February 15, 2022)
- Description of Capital Shares (Filed With SEC on February 15, 2022)
- Letter Agreement dated April 29, 2021 by and between CRISPR Therapeutics, Inc. and Pfizer Inc (Filed With SEC on July 29, 2021)
- Description of Capital Shares (Filed With SEC on February 16, 2021)
- Option Agreement, dated December 13, 2019, between CRISPR Therapeutics AG and Bayer HealthCare LLC (Filed With SEC on February 12, 2020)
- Description of Capital Shares (Filed With SEC on February 12, 2020)
- Open Market Sale AgreementSM, dated August 30, 2019, by and between CRISPR Therapeutics AG and Jefferies LLC (Filed With SEC on August 30, 2019)
- Open Market Sale AgreementSM, dated August 31, 2018, by and between CRISPR Therapeutics AG and Jefferies LLC (Filed With SEC on August 31, 2018)
